Jason Rando | Tiberend Strategic Adviser |
David Arthur | Director & Chief Executive Officer |
Mark Rosenblum | Chief Financial Officer |
Daniela Santiesteban | Director, Research and Business Development |
Aydin Huseynov | Benchmark |
Hunter Diamond | Diamond Equity Research |
Ladies and gentlemen, thank you for standing by, and welcome to the Q3 2020 Salarius Pharmaceutical Earnings Webcast and Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is begin recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, to Mr.